Click here to view the poster gallery. Nominees should have had a track record in participating in the CAPT conference as an attendee, a poster participant, a presenter, a moderator, or a speaker. She has completed a Masters in Health Economics at the University of York, UK and recently completed a Masters in Epidemiology from the London School of Hygiene and Tropical Medicine. Contribution to CAPT. She is a Fellow of both DIA and the Int’l Society of Pharmacoepidemiology. In 1996, she joined Janssen-Ortho’s Government and Health Economics Department in a market access strategy and submissions role. The nomination criteria used to identify potential nominees includes three areas: Marjorie Morrison is the Executive Director of the Canadian Association for Population Therapeutics. The Nairobi Summit on ICPD25: Accelerating the promise will be held in Nairobi, Kenya, from 12-14 November, 2019. She has over 15 years’ experience in the pharmaceutical industry, with expertise in clinical research, pricing and reimbursement, health technology assessment and real-world evidence generation and obtained a Bachelor of Science (BSc) degree in Pharmacy in Taiwan and graduated from the University of British Columbia with an MBA degree. Charity 1114109, Company 3019081,135-137 Station Road, London E4 6AG, UK. She focuses on generating real-world evidence for regulators, clinicians, patients and payers through pragmatic trials and non-interventional approaches, and has more than 100 publications research publications. He received his PhD in biophysics and molecular pharmacology from the Leslie L. Dan Faculty of Pharmacy at the University of Toronto. The successful nominee is selected by the CAPT board with the award presented during a ceremony at the Annual Conference. Our population is expected to grow to over 9 billion by 2050, yet the ability of our environment to provide space, food, and energy are limited. Shanna’s doctoral work has been supported by the Nova Scotia Health Research Foundation, the Dalhousie Pharmacy Endowment Fund, the Canadian Society of Hospital Pharmacists’ Foundation, the Canadian Frailty Network, and the Faculty of Graduate Studies at Dalhousie University. The Johns Hopkins Center for Health Security in partnership with the World Economic Forum and the Bill and Melinda Gates Foundation hosted Event 201, a high-level pandemic exercise on October 18, 2019, in New York, NY. Population growth has a significantly higher impact in areas of the world with the highest biodiversity, posing a considerable threat to these species-rich regions. There is widespread consensus among scientists and conservationists that we are in the midst of the Sixth Mass Extinction, and that its cause is anthropogenic (by humans). There is widespread consensus among scientists and conservationists that we are in the midst of the Sixth Mass Extinction, and that its cause is anthropogenic (by humans). Rethinking population ageing in the SDG era According to World Population Prospects 2019 (United Nations, 2019), by 2050, 1 in 6 people in the world will be over the age of 65, up from 1 in 11 in 2019 UNITED NATIONS, New York, 18 January 2019 — The Government of the Republic of Kenya and the United Nations Population Fund (UNFPA) today announced the convening of a high-level conference to advance the implementation of the International Conference on Population and Development (ICPD) Programme of Action. During a career with Janssen spanning 18 years, Ms. Robinson held increasingly senior roles in health economics, pricing, government affairs, and as a member of the market access Leadership Team. Winners of the Dr. E. Keith Borden Award for Student Presentation are: Characteristics of a population exposed to a disease-modifying drug for multiple sclerosis in the real-world setting (1996-2017) Shoghag Khoudigian is a Senior Consultant in the Health Access and Outcomes, Real World Evidence Solutions at IQVIA (Toronto) and has 4-years of experience in in the pharmaceutical industry in Market Access, and 4 years of experience in academia in Health Technology Assessment (HTA). She has been a Standing Consultant to the National Football League Health & Safety Executive Committee since 2013. Session 5: Pharmacoeconomic Analysis and Outcome-based agreements: What does it mean for Canadian Private Payers? Click on the name of the country or dependency for current estimates (live population clock), historical data, and … Ambassador Lazarus Ombai Amayo, the Permanent Representative of Kenya to the United Nations, said, “Kenya is committed to the full implementation of the principles and goals of the ICPD Programme of Action. As the world’s population grows, so does demand for food, water, land, timber, fossil fuels and other resources, which places great pressures on ecosystems and drives biodiversity loss. During the conference, leaders articulated a bold vision regarding the relationships between population, development and individual well-being. Countries in the world by population (2020) This list includes both countries and dependent territories.Data based on the latest United Nations Population Division estimates. She holds an appointment as Adjunct Professor of Epidemiology at the Gillings School of Global Public Health at the University of North Carolina and is a two-time recipient of PharmaVOICE magazine’s annual list of 100 most influential and inspiring individuals in life sciences.”. Asia is the most populous continent, with its 4.64 billion inhabitants accounting for 60% of the world population. In 2013, she left Janssen to form PharmaKARe Consulting, a market access and pricing consultancy to the pharmaceutical and medical devices industries. The Nairobi Summit on ICPD25: Accelerating the promise will be held in Nairobi, … ICPD Through the Lens of Reproductive Justice, Promises to keep: Meeting the Nairobi Summit commitments. We look forward to working with UNFPA, UN Member States and other partners on this important event that will celebrate the significant achievements of the ICPD Agenda and further promote the global development agenda.”, “As we celebrate the remarkable progress we have made in advancing the health and rights of women, we must redouble our efforts to reach those who have not yet benefited from the promise of the ICPD,” said Dr. Natalia Kanem, UNFPA Executive Director. Kimberly Robinson studied Biology at Queen’s University in Kingston, Ontario, graduating with a BScH, in 1988. Service to CAPT. Graeme Ball is a Health Economics and Reimbursement Manager with Janssen in Toronto where he is responsible for reimbursement strategy and submissions for oncology products. Prior to her public service career, she held various consulting positions with Brogan Inc. and holds a Master of Arts in Economics. Prior to this role, Peter held various roles at Janssen Inc. focused on health technology assessment (HTA) submissions, health economics, and data generation. Peter Dyrda is the Strategic Access Manager at the Canadian operating company of Janssen Inc. The world's two most populated countries, China and India, together constitute about 36% of the world's population. Thanks to the Nairobi Summit, we know what needs to be done to realize a world of rights and choices for all. Kimberly joined the Ontario Public Service in 1990, working in a program area for 4 years and in a policy analysis role for 18 months. Nancy Dreyer is Chief Scientific Officer and SVP at IQVIA. “The Nairobi Summit will help us rally a broad coalition of stakeholders to protect the gains made and advance the ICPD agenda to ensure that no one is left behind.”, At the Kenya Mission to the United Nations: At UNFPA: Omar Gharzeddine, +1 212 297 5028, Peter holds an MBA with a Healthcare Services Specialization and a BSc in Biology & Pharmacology, both from McMaster University in Hamilton, Ontario. Wanrudee Isaranuwatchai is a Research Scientist and Director of the Centre for Excellence in Economic Analysis Research (CLEAR) at St. Michael’s Hospital, as well as an Assistant Professor at the Institute of Health Policy, Management and Evaluation, University of Toronto. He has also worked as a Health Economist at the PATH Research Institute in Canada. Poster # 31, Reimbursement Recommendations of Conditionally-Approved Cancer Drugs in Canada Please check out the directions via tube, bus, car, rail, bike, and the airport. She holds a PhD in Health Research Methodology, specializing in HTA, at the Programs of Assessment of Technology in Health (PATH) Research Institute (affiliated with McMaster University) and an Honors Bachelor degree in Biology and Pharmacology with a minor in Economics and Biochemistry also from McMaster University. This year marks the 25th anniversary of the ground breaking International Conference on Population and Development, which took place in Cairo in 1994. CAPT-ACTP gratefully acknowledges our 2020 partners: All accepted abstract will be published post conference in The Journal of Population Therapeutics & Clinical Pharmacology, Posters presentations can be accessed via our online poster gallery here, Copyright 2019 CAPT-ACTP. Elena Lungu is the Manager of the National Prescription Drug Utilization Information System (NPDUIS) initiative of the Patented Medicine Prices Review Board (PMPRB) and has been with the PMPRB for over a decade where she leads the NPDUIS initiative, with a focus on price, utilization and cost trends in support of policy decisions. Event 201. Nominees should have had a role in creating, sustaining, reshaping, or re-vitalizing CAPT over the years. She completed her BScPharm and MAHSR at Dalhousie University. UNFPA Executive Director Dr. Natalia Kanem was joined by leading figures from the reproductive justice movement and practitioners in the field for a global conversation on why reproductive justice matters today and how it relates to sexual and reproductive health and rights. She then went on to earn an MBA at McGill University in 1990. His current research focuses on cost-effectiveness methods and survival analysis in oncology. Previously, she served as the Chief Executive Officer of the Canadian Cancer Action Network for 10-years where her work with cancer patient advocacy organizations and Canadian cancer control stakeholders focused primarily in the areas of patient engagement, family caregivers, knowledge translation and health technology assessment. He holds a BA in Economics, a MA in Economic Policy and Health Economics, and is currently completing a PhD in Health Research Methodology specializing in HTA at McMaster University. Prior to joining Janssen, Graeme worked as a Consultant at IQVIA in Tokyo where he managed HEOR projects throughout the Asia-Pacific region including real-world evidence studies, pharmacoeconomic modeling, publications, and quantitative analytics. A trained IAP2 public participation practitioner and an CSAE Certified Association Executive, she is an alumnus of the University of Regina and a Master of Health Administration candidate in her second year of graduate studies with the Johnson Shoyama School of Public Policy, Regina, Saskatchewan.